Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A genetically engineered cell-based biosensor for functional classification of agents.

A M Aravanis1, B D DeBusschere, A J Chruscinski

  • 1Department of Electrical Engineering, CISX 202X, Stanford University, Stanford, CA 94305-4075, USA.

Biosensors & Bioelectronics
|September 7, 2001
PubMed
Summary

Genetically-engineered cell-based biosensors (GECBBs) overcome limitations in detecting biological agents by using wild-type and knockout cells. This novel biosensor approach offers specific functional activity assays and simplified signal analysis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Local membrane charge regulates β<sub>2</sub> adrenergic receptor coupling to G<sub>i3</sub>.

Nature communications·2019
Same author

The glucocorticoid receptor gene polymorphism N363S predisposes to more severe toxic side effects during pediatric acute lymphoblastic leukemia (ALL) therapy.

International journal of hematology·2013
Same author

Functioning of families with primary school-age children conceived using anonymous donor sperm.

Human reproduction (Oxford, England)·2012
Same author

Decreased hormone content of immune cells in children during acute lymphocytic leukemia (ALL) - effect of treatment.

Acta microbiologica et immunologica Hungarica·2011
Same author

Adrenergic Receptors From Molecular Structure to in vivo function.

Trends in cardiovascular medicine·2011
Same author

Synergistic interaction of ABCB1 and ABCG2 polymorphisms predicts the prevalence of toxic encephalopathy during anticancer chemotherapy.

The pharmacogenomics journal·2007

Area of Science:

  • Biotechnology
  • Biosensor Technology
  • Cellular Engineering

Background:

  • Traditional cell-based biosensors (CBBs) struggle to classify agents due to pathway cross-talk.
  • Difficulty in distinguishing specific biological agents based solely on cellular response.
  • Need for improved biosensor specificity and simplified signal analysis.

Purpose of the Study:

  • To develop a genetically-engineered cell-based biosensor (GECBB) for specific agent detection.
  • To translate cross-talk noise into rejectable common-mode noise.
  • To create a biosensor sensitive to agents activating the beta 1-adrenergic receptor (beta 1-AR).

Main Methods:

  • Utilized two cell populations: wild-type (WT) and receptor-knockout (KO) cells.
  • Assayed differential activation of WT and KO cells to identify specific agents.

Related Experiment Videos

  • Measured spontaneous beat rate of cardiomyocytes using microelectrode arrays as the cellular signal.
  • Engineered GECBBs in mouse cardiomyocytes lacking beta 1-AR.

    • Main Results:

    • The GECBB demonstrated exquisite sensitivity to agents affecting the engineered pathway.
    • Successfully detected the beta-AR agonist isoproterenol (ISO) at 10 microM (P<0.005).
    • The GECBB approach simplified signal analysis compared to traditional CBBs.

    Conclusions:

    • GECBBs offer a robust method for specific functional activity assays.
    • This technology effectively rejects cross-talk noise, enhancing biosensor specificity.
    • The developed GECBB is a promising tool for detecting specific biological agents, exemplified by beta 1-AR activation.